Clinical trial
Development of NIC5-15 in the Treatment of Alzheimer's Disease
NCT00470418 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00470418 |
|---|---|
| Title | Development of NIC5-15 in the Treatment of Alzheimer's Disease |
| Official title | Development of NIC5-15 in the Treatment of Alzheimer's Disease |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH Humanetics Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer Disease, Dementia |
| Intervention type | Drug |
| Interventions | NIC5-15, Placebo |
| Enrollment | 15 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Mar 1, 2010 |
| First posted | May 7, 2007 |
| Last update posted | Jan 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: